Market Place
Sourcing Support
Supreme Court Ask to Intervene in Mail-order Abortion pill fight
03 May 2026 //
FIRSTWORD PHARMA
NAFDAC Warns of Fake Augmentin 625mg in Nigeria
03 May 2026 //
NAFDAC
Several State Still Not File NSQ Data with Central Drug Regulator
02 May 2026 //
PHARMABIZ
InspireMD Initiates Voluntary Recall of CGuard Delivery System
01 May 2026 //
GLOBENEWSWIRE
ORS Sales Melt In March After Govt`s Stricter Labelling Norms
01 May 2026 //
ECONOMICTIMES
Patient death prompts FDA pause on Newron’s Phase 3 schizophrenia
01 May 2026 //
BIOSPACE
Leanzene Gummies Under Investigation Avoid Fake Complaints & Risk
30 Apr 2026 //
GLOBENEWSWIRE
House Panel Urges Ban on China Data in FDA Approvals
30 Apr 2026 //
ENDPOINTS
FDA Proposes Excluding Semaglutide, Tirzepatide, Liraglutide
30 Apr 2026 //
FDA
FDA Warns Three Firms For GMP Violations, Cites Incyte
30 Apr 2026 //
RAPS
Lilly Backs Haryana State-Fda Against Counterfeit Medicines
30 Apr 2026 //
EXPRESSPHARMA
FDA Risk Management Biggest Hurdle For Inspections Under QMSR
28 Apr 2026 //
RAPS
Gujarat Government Bolsters Drug And Cosmetics Regulation
28 Apr 2026 //
PHARMABIZ
B. Braun Recalls Lactated Ringer`s Injection, 1L
28 Apr 2026 //
FIRSTWORD PHARMA
Britain`s Lifetime Smoking Ban Set To Become Law
27 Apr 2026 //
REUTERS
FDA Offers Tips On Verifying, Validating Manufacturing Processes
24 Apr 2026 //
RAPS
Probe Urged As Badlapur Fertility Injection Scam Unveiled
23 Apr 2026 //
PHARMABIZ
Pharma Files Citizen Petition Against Fda Rejection Letters
23 Apr 2026 //
BIOSPACE
Citizen Petition Calls On FDA To Tighten Up CRL Disclosures
23 Apr 2026 //
FIERCE PHARMA
FDA Addresses Resourcing Issues Amid Rise In 2025 Class I Recalls
23 Apr 2026 //
RAPS
Omega Pharma Ltd Recalls Napralief 250Mg Gastro-Resistant Tablets
23 Apr 2026 //
FIRSTWORD PHARMA
Grace Therapeutics Updates On Gtx-104 Drug Application
23 Apr 2026 //
GLOBENEWSWIRE
Different Packaging, Typos Expose Fake Mounjaro Racket
23 Apr 2026 //
ECONOMICTIMES
Pharma Petition Urges FDA Reform On Drug Rejection Letter
22 Apr 2026 //
ENDPOINTS NEWS
USFDA Issues Form-483 To Ajanta Pharma`s Paithan Facility
22 Apr 2026 //
ECONOMICTIMES
Govt Ammonia Rule Curbs Pharma Surplus Sales to Fertiliser Firms
22 Apr 2026 //
ECONOMICTIMES
FDA issues warning letter after GLP-1 manufacturer
22 Apr 2026 //
FDA
FDA Cites Drug Manufacturers, Compounders Over Sterility Issues
21 Apr 2026 //
RAPS
Eli Lilly Issues Statement On Counterfeit Mounjaro Case
21 Apr 2026 //
ECONOMICTIMES
Drug regulator transfers 95 officials in mass reshuffle
20 Apr 2026 //
ECONOMICTIMES
Theramex exits self-regulatory body after compliance failures
20 Apr 2026 //
FIERCE PHARMA
Eli Lilly flags counterfeit Mounjaro seizure in Gurugram
20 Apr 2026 //
INDPHARMAPOST
NGO Urges Drug Regulator to Oversee Nutraceuticals
19 Apr 2026 //
ECONOMICTIMES
Morepen Labs Secures 4th Straight USFDA NIL 483 Inspection
17 Apr 2026 //
INDPHARMAPOST
FDA Warns Firm For Inappropriate Use Of AI In Drug Manufacturing
17 Apr 2026 //
RAPS
More transparency, evidence needed for accelerated nods: ICER
17 Apr 2026 //
FIERCE PHARMA
Teva, Viatris launch separate recalls in the US
17 Apr 2026 //
FIERCE PHARMA
FDA Cracks Down on Drug Ads with 3 Untitled Letters
15 Apr 2026 //
RAPS
Pfizer Rebuked By FDA For Misleading Adcetris Ads On Facebook
14 Apr 2026 //
FIERCE PHARMA
Indoco Remedies & Panacea Biotec: Key Briefs
14 Apr 2026 //
INDPHARMAPOST
CS Analytical Names Roark as Director of Scientific Affairs
14 Apr 2026 //
PR NEWSWIRE
DCC Reclassifies 4 Drugs from H to H1 for Stricter Controls
13 Apr 2026 //
PHARMABIZ
FDA Boosts Biopharma Accountability With CRL Transparency
13 Apr 2026 //
BIOSPACE
Unichem US Arm Recalls Buspirone After Failed Stability Test
13 Apr 2026 //
INDPHARMAPOST
Ayco Farms Clarifies FDA Enforcement Report Listing
10 Apr 2026 //
BUSINESSWIRE
DTAB Urges Scrapping Draft Ban on Schedule G Drug Ads
10 Apr 2026 //
PHARMABIZ
Amneal, Biocorrx Accused Of `False And Misleading` Promotions
10 Apr 2026 //
FIERCE PHARMA
HCG Bengaluru Promotes Distress Screening as Vital Sign
09 Apr 2026 //
INDPHARMAPOST
BIOFIRE SPOTFIRE Revolutionizes Mycoplasma Testing In Pharma
09 Apr 2026 //
PR NEWSWIRE
FDA Warns Texas Medical Spa For Botox Dispensing Discrepancies
09 Apr 2026 //
RAPS
Blaine Labs Recalls Wound Care Gels Over Contamination
08 Apr 2026 //
BUSINESSWIRE
Health Canada Revises GMP Guide for Natural Health Products
07 Apr 2026 //
PHARMIWEB
Health officials warn of veterinary sedative in illegal drug
07 Apr 2026 //
REUTERS
TNCDA Files Complaint Against Tata 1mg for Drug Violations
06 Apr 2026 //
PHARMABIZ
DTAB Calls for Revision of Microbial Contamination Limits
06 Apr 2026 //
PHARMABIZ
Immunitybio Responds To FDA Warning Letter With New Protocols
06 Apr 2026 //
FIERCE PHARMA
Indian Pharma Faces Supply Risk Amid West Asia Conflict
02 Apr 2026 //
ECONOMICTIMES
Government Ensures Safety Of GLP-1 Drugs Amid Weight-Loss Hype
01 Apr 2026 //
ECONOMICTIMES
Midst Global Headwinds, CDSCO Cracks Down On GLP-1 Gold Rush
01 Apr 2026 //
EXPRESSPHARMA
Panel Urges Timely Actions To Fill CDSCO Vacancies
31 Mar 2026 //
PHARMABIZ
